IL160329A0 - 2-amino-4,5-trisubstituted thiazolyl derivatives - Google Patents

2-amino-4,5-trisubstituted thiazolyl derivatives

Info

Publication number
IL160329A0
IL160329A0 IL16032902A IL16032902A IL160329A0 IL 160329 A0 IL160329 A0 IL 160329A0 IL 16032902 A IL16032902 A IL 16032902A IL 16032902 A IL16032902 A IL 16032902A IL 160329 A0 IL160329 A0 IL 160329A0
Authority
IL
Israel
Prior art keywords
amino
thiazolyl derivatives
trisubstituted
trisubstituted thiazolyl
derivatives
Prior art date
Application number
IL16032902A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL160329A0 publication Critical patent/IL160329A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL16032902A 2001-08-13 2002-08-09 2-amino-4,5-trisubstituted thiazolyl derivatives IL160329A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203087 2001-08-13
PCT/EP2002/008955 WO2003015773A2 (en) 2001-08-13 2002-08-09 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases

Publications (1)

Publication Number Publication Date
IL160329A0 true IL160329A0 (en) 2004-07-25

Family

ID=8180790

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16032902A IL160329A0 (en) 2001-08-13 2002-08-09 2-amino-4,5-trisubstituted thiazolyl derivatives
IL160329A IL160329A (en) 2001-08-13 2004-02-11 2-amino-4,5-trisubstituted thiazolyl derivatives, uses thereof for the manufacture of a medicament, pharmaceutical compositions containing them and process of preparation thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160329A IL160329A (en) 2001-08-13 2004-02-11 2-amino-4,5-trisubstituted thiazolyl derivatives, uses thereof for the manufacture of a medicament, pharmaceutical compositions containing them and process of preparation thereof

Country Status (21)

Country Link
US (2) US7232838B2 (es)
EP (1) EP1418909B1 (es)
JP (1) JP4388805B2 (es)
KR (2) KR101034489B1 (es)
CN (1) CN100496493C (es)
AU (1) AU2002324045C1 (es)
BR (1) BR0211887A (es)
CA (1) CA2451980C (es)
EA (1) EA007717B1 (es)
ES (1) ES2407807T3 (es)
HK (1) HK1069997A1 (es)
HR (1) HRP20040097B1 (es)
HU (1) HUP0401748A3 (es)
IL (2) IL160329A0 (es)
MX (1) MXPA04001399A (es)
NO (1) NO327409B1 (es)
NZ (1) NZ530950A (es)
PL (1) PL368130A1 (es)
UA (1) UA82176C2 (es)
WO (1) WO2003015773A2 (es)
ZA (1) ZA200401162B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3836019B2 (ja) * 2001-11-21 2006-10-18 松下電器産業株式会社 受信装置、送信装置及び送信方法
AR044519A1 (es) * 2003-05-02 2005-09-14 Novartis Ag Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
KR20060129413A (ko) * 2004-01-30 2006-12-15 에이비 사이언스 티로신 키나제 억제제로서의2-(3-치환된-아릴)아미노-4-아릴-티아졸
EA200702445A1 (ru) 2005-05-09 2008-04-28 Ачиллион Фармасьютикалз, Инк. Соединения тиазола и способы их применения
WO2006128172A2 (en) * 2005-05-26 2006-11-30 Synta Pharmaceuticals Corp. Method for treating b cell regulated autoimmune disorders
EA015034B1 (ru) * 2005-09-13 2011-04-29 Янссен Фармацевтика Н.В. 2-анилин-4-арилзамещенные тиазольные производные
CN101384568B (zh) * 2006-02-15 2012-12-12 雅培制药有限公司 乙酰辅酶a羧化酶(acc)抑制剂及其在糖尿病、肥胖症和代谢综合征中的应用
WO2007095602A2 (en) 2006-02-15 2007-08-23 Abbott Laboratories Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
JP2009529059A (ja) * 2006-03-08 2009-08-13 アキリオン ファーマシューティカルズ,インコーポレーテッド 抗c型肝炎ウイルス活性を有する置換アミノチアゾール誘導体
PL2402319T3 (pl) 2006-03-31 2018-02-28 Novartis Ag Inhibitory DGAT
JP2010528019A (ja) 2007-05-22 2010-08-19 アキリオン ファーマシューティカルズ,インコーポレーテッド ヘテロアリール置換チアゾール
JP5457344B2 (ja) * 2007-07-17 2014-04-02 アセア バイオサイエンシズ インコーポレイテッド 複素環式化合物および抗がん剤としての使用
AR066169A1 (es) 2007-09-28 2009-07-29 Novartis Ag Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat
CA2697974C (en) 2007-10-18 2015-06-30 Janssen Pharmaceutica Nv Trisubstituted 1,2,4-triazoles
JO2784B1 (en) 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
PE20091523A1 (es) 2007-12-20 2009-10-29 Novartis Ag Derivados de tiazol como inhibidores de la enzima fosfatidilinositol 3-cinasa (pi3k)
US20110105436A1 (en) * 2008-03-10 2011-05-05 Auckland Uniservices Limited Heteroaryl compounds, compositions, and methods of use in cancer treatment
MX2010010127A (es) 2008-03-19 2010-10-25 Janssen Pharmaceutica Nv 1,2,4-triazoles trisustituidos como moduladores de receptores de acetilcolina nicotinicos.
AU2009245715B2 (en) 2008-05-09 2014-01-09 Janssen Pharmaceutica Nv Trisubstituted pyrazoles as acetylcholine receptor modulators
US8106209B2 (en) * 2008-06-06 2012-01-31 Achillion Pharmaceuticals, Inc. Substituted aminothiazole prodrugs of compounds with anti-HCV activity
WO2010002985A1 (en) 2008-07-01 2010-01-07 Ptc Therapeutics, Inc. Bmi-1 protein expression modulators
UA104147C2 (uk) 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
CA2739322A1 (en) * 2008-10-01 2010-04-08 Synta Pharmaceuticals Corp. Compounds for inflammation and immune-related uses
US8293753B2 (en) * 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
SG11201401207XA (en) * 2011-10-04 2014-05-29 Inst Hepatitis & Virus Res Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication
CN103159695B (zh) * 2011-12-08 2015-08-12 首都师范大学 可抑制hiv复制并对耐药hiv病毒株有效的噻唑类化合物及其制备方法和用途
CN102863435B (zh) * 2012-09-25 2015-02-18 盐城工学院 一种2-[[4-氟-3-(三氟甲基)苯基]氨基]-4-吡啶基-5-噻唑甲醛及其还原产物的制备方法
US9453002B2 (en) 2013-08-16 2016-09-27 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers
US11072592B2 (en) 2015-02-27 2021-07-27 The Regents Of The University Of California Small molecules that enable cartilage rejuvenation
KR20170001969U (ko) 2015-11-27 2017-06-07 주식회사 바이오해저드특수청소 조류 퇴치기
CN105524056A (zh) * 2016-01-05 2016-04-27 中山大学肿瘤防治中心 一种氨基噻唑化合物及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
BE795907A (fr) * 1972-02-25 1973-06-18 Luso Farmaco Inst 2-amino-4-arylthiazoles 5-substitues et leur preparation
US4649146A (en) * 1983-01-31 1987-03-10 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives and pharmaceutical composition comprising the same
EP0149884B1 (en) * 1983-09-09 1992-12-16 Takeda Chemical Industries, Ltd. 5-pyridyl-1,3-thiazole derivatives, their production and use
DE3406232A1 (de) 1984-02-21 1985-08-29 Bayer Ag, 5090 Leverkusen Faserreaktive formazanfarbstoffe
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone
JPS6267022A (ja) 1985-09-18 1987-03-26 Otsuka Pharmaceut Factory Inc 抗炎症剤
US5000775A (en) * 1985-12-31 1991-03-19 Monsanto Company 2-amino-4,5-disubstituted-oxazole/thiazole compounds as herbicide antidotes
JPH07149745A (ja) 1993-11-30 1995-06-13 Hisamitsu Pharmaceut Co Inc 新規な2−アミノチアゾール誘導体
CA2206315A1 (en) * 1994-11-29 1996-06-06 Hisamitsu Pharmaceutical Co., Inc. Antibacterial preparation or bactericide comprising 2-aminothiazole derivative and/or salt thereof
JP3310299B2 (ja) 1995-11-23 2002-08-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 溶融−押し出しにより調製されるシクロデキストリンの固体混合物
WO1999064418A1 (en) 1998-06-05 1999-12-16 Novartis Ag Aryl pyridinyl thiazoles
CA2397661C (en) 2000-03-01 2012-01-03 Janssen Pharmaceutica N.V. 2,4-disubstituted thiazolyl derivatives
US6403588B1 (en) * 2000-04-27 2002-06-11 Yamanouchi Pharmaceutical Co., Ltd. Imidazopyridine derivatives
AU2001295992A1 (en) 2000-10-24 2002-05-06 Sankyo Company Limited Imidazopyridine derivatives

Also Published As

Publication number Publication date
UA82176C2 (en) 2008-03-25
ZA200401162B (en) 2005-07-27
US7803823B2 (en) 2010-09-28
AU2002324045B2 (en) 2007-10-04
EA200400306A1 (ru) 2004-08-26
KR101034489B1 (ko) 2011-05-17
HUP0401748A3 (en) 2011-03-28
CA2451980C (en) 2012-12-11
WO2003015773A2 (en) 2003-02-27
NO327409B1 (no) 2009-06-22
AU2002324045C1 (en) 2008-05-29
PL368130A1 (en) 2005-03-21
KR20100076043A (ko) 2010-07-05
BR0211887A (pt) 2004-09-21
US7232838B2 (en) 2007-06-19
CN1541097A (zh) 2004-10-27
HRP20040097B1 (hr) 2013-10-11
KR100979988B1 (ko) 2010-09-03
US20040254191A1 (en) 2004-12-16
EP1418909A2 (en) 2004-05-19
IL160329A (en) 2010-05-31
JP4388805B2 (ja) 2009-12-24
WO2003015773A3 (en) 2003-12-18
NZ530950A (en) 2006-03-31
HRP20040097A2 (en) 2004-06-30
MXPA04001399A (es) 2004-05-27
EP1418909B1 (en) 2013-02-20
NO20040632L (no) 2004-03-11
KR20040031712A (ko) 2004-04-13
ES2407807T3 (es) 2013-06-14
HK1069997A1 (en) 2005-06-10
HUP0401748A2 (hu) 2004-12-28
CA2451980A1 (en) 2003-02-27
EA007717B1 (ru) 2006-12-29
US20070203189A1 (en) 2007-08-30
CN100496493C (zh) 2009-06-10
JP2005501099A (ja) 2005-01-13

Similar Documents

Publication Publication Date Title
HK1069997A1 (en) 2-amino-4,5-trisubstituted thiazolyl derivatives 2-4,5-
IL161623A0 (en) Nicotin-or isonicotin benzothiazole derivatives
IL162721A0 (en) 2-(Pyridin-2-ylamino)-pyridoÄ2,3-dÜpyrimidin-7-ones
ZA200401015B (en) Compounds effecting glucokinase.
PL370978A1 (en) Benzothiazole derivatives
HK1062911A1 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
HK1090368A1 (en) 2,3,6-trisubstituted-4-pyrimidone derivatives
AP2005003198A0 (en) Spiroindolinepiperidine derivatives.
ZA200500170B (en) Indole-3-sulphur derivatives.
MXPA03009097A (es) Derivados de benzamidina.
EP1392664A4 (en) EPOTHILONE DERIVATIVES
MX267068B (es) Derivados simetricos de triazina.
AU2002341195A1 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
HK1077507A1 (en) 2,4,5-trisubstituted thiazolyl derivatives ant their antiinflammatory activity
HK1068608A1 (en) 3-Substituted-4-pyrimidone derivatives
AU2002367186A1 (en) Urea derivatives
SI1699795T1 (sl) Substituirani 8-piri(mi)dinil-dihidrospiro-(cikloalkilamin)pirimido(1,2a) pirimidin-6-onski derivati
AU2002358700A8 (en) Urea derivatives as vr1- antagonists
MXPA03006773A (es) Derivados de imidazol.
IL158388A0 (en) Novel arylheteroalkylamine derivatives
MXPA03008338A (es) Derivados de piperazina.
MXPA03008140A (es) Amidas de acido benzofuran-2-carboxilico sustituidas.
HK1068607A1 (en) Phenylalkyloxy-phenyl derivatives
HUP0500026A3 (en) N-heteroarylnicotinamide derivatives
MXPA03001269A (es) Nuevos derivados de aminociclohexano.